XML 82 R65.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Weighted Average Assumptions of Stock Options | The following table sets forth the weighted-average assumptions used at the respective grant dates to determine the fair values of the Company’s stock option awards granted during the years ended December 31, 2024, 2023 and 2022.
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
Risk-free interest rate |  |  | 4.45 | % |  |  | 4.18 | % |  |  | 1.61 | %
Expected term (years) |  |  | 6.00 |  |  |  | 6.00 |  |  |  | 6.00 |
Volatility |  |  | 49.02 | % |  |  | 55.63 | % |  |  | 56.71 | %
Dividend yield |  |  | 3.64 | % |  |  | 2.87 | % |  |  | 3.85 | %
Fair value per stock option |  | $ | 10.28 |  |  | $ | 15.36 |  |  | $ | 9.89 |
The following table sets forth the assumptions used at the grant date to determine the fair value of the Company's performance stock option awards granted during the years ended December 31, 2024 and 2023.
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Risk-free interest rate |  |  | 4.43 | % |  |  | 4.13 | %
Expected term (years) |  |  | 6.09 |  |  |  | 7.00 |
Volatility |  |  | 48.91 | % |  |  | 56.32 | %
Dividend yield |  |  | 3.64 | % |  |  | 2.87 | %
Fair value per performance stock option (1) |  | $ | 10.05 |  |  | $ | 14.97 |
(1) Represents the weighted-average fair value at each point of projected exercise under the Monte Carlo valuation method.
Schedule of Stock Options Activity | The following table sets forth Chemours’ stock option activity for the years ended December 31, 2024, 2023 and 2022.
|  | Number of Shares (in Thousands) |  |  | Weighted-average Exercise Price (per Share) |  |  | Weighted-average Remaining Contractual Term (in Years) |  |  | Aggregate Intrinsic Value (in Thousands) |
Outstanding, December 31, 2021 |  |  | 6,967 |  |  | $ | 20.32 |  |  |  | 6.60 |  |  | $ | 101,261 |
Granted |  |  | 1,031 |  |  |  | 25.98 |  |  |  |  |  |  |
Exercised |  |  | (3,041 | ) |  |  | 16.76 |  |  |  |  |  |  |
Forfeited |  |  | (202 | ) |  |  | 21.29 |  |  |  |  |  |  |
Expired |  |  | (87 | ) |  |  | 32.78 |  |  |  |  |  |  |
Outstanding, December 31, 2022 |  |  | 4,668 |  |  | $ | 23.61 |  |  |  | 7.08 |  |  | $ | 42,668 |
Granted |  |  | 560 |  |  |  | 34.82 |  |  |  |  |  |  |
Exercised |  |  | (1,153 | ) |  |  | 16.84 |  |  |  |  |  |  |
Forfeited |  |  | (296 | ) |  |  | 29.04 |  |  |  |  |  |  |
Expired |  |  | (169 | ) |  |  | 39.02 |  |  |  |  |  |  |
Outstanding, December 31, 2023 |  |  | 3,610 |  |  | $ | 26.35 |  |  |  | 6.51 |  |  | $ | 27,760 |
Granted |  |  | 705 |  |  |  | 27.50 |  |  |  |  |  |  |
Exercised |  |  | (453 | ) |  |  | 18.23 |  |  |  |  |  |  |
Forfeited |  |  | (290 | ) |  |  | 30.01 |  |  |  |  |  |  |
Expired |  |  | (267 | ) |  |  | 40.04 |  |  |  |  |  |  |
Outstanding, December 31, 2024 |  |  | 3,305 |  |  | $ | 26.28 |  |  |  | 6.22 |  |  | $ | 3,294 |
Exercisable, December 31, 2024 |  |  | 2,319 |  |  | $ | 25.27 |  |  |  | 5.12 |  |  | $ | 3,307 |
|  | Number of Shares (in Thousands) |  |  | Weighted-average Exercise Price (per Share) |  |  | Weighted-average Remaining Contractual Term (in Years) |  |  | Aggregate Intrinsic Value (in Thousands) |
Outstanding, December 31, 2022 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Granted |  |  | 239 |  |  |  | 38.32 |  |  |  |  |  |  |
Vested |  |  | — |  |  |  | — |  |  |  |  |  |  |
Forfeited |  |  | (64 | ) |  |  | 38.32 |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | — |  |  |  |  |  |  |
Outstanding, December 31, 2023 |  |  | 175 |  |  | $ | 38.32 |  |  |  | 9.17 |  |  | $ | — |
Granted |  |  | 204 |  |  |  | 30.25 |  |  |  |  |  |  |
Vested |  |  | — |  |  |  | — |  |  |  |  |  |  |
Forfeited |  |  | (97 | ) |  |  | 37.27 |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | — |  |  |  |  |  |  |
Outstanding, December 31, 2024 |  |  | 282 |  |  | $ | 32.85 |  |  |  | 8.97 |  |  | $ | — |
Exercisable, December 31, 2024 |  |  | 57 |  |  | $ | 38.32 |  |  |  | 8.17 |  |  | $ | — |
Schedule of Restricted Stock Units Activity | The following table sets forth non-vested RSUs at December 31, 2024, 2023 and 2022.
|  | Number of Shares (in Thousands) |  |  | Weighted-average Grant Date Fair Value (per Share) |
Non-vested, December 31, 2021 |  |  | 1,159 |  |  | $ | 22.20 |
Granted |  |  | 388 |  |  |  | 28.08 |
Vested |  |  | (473 | ) |  |  | 20.97 |
Forfeited |  |  | (77 | ) |  |  | 21.75 |
Non-vested, December 31, 2022 |  |  | 997 |  |  | $ | 25.10 |
Granted |  |  | 497 |  |  |  | 33.22 |
Vested |  |  | (391 | ) |  |  | 20.71 |
Forfeited |  |  | (236 | ) |  |  | 18.84 |
Non-vested, December 31, 2023 |  |  | 867 |  |  | $ | 30.86 |
Granted |  |  | 430 |  |  |  | 25.02 |
Vested |  |  | (343 | ) |  |  | 28.65 |
Forfeited |  |  | (152 | ) |  |  | 32.50 |
Non-vested, December 31, 2024 |  |  | 802 |  |  | $ | 28.36 |
Schedule of Performance Share Units Activity | The following table sets forth non-vested PSUs at 100% of target amounts at December 31, 2024, 2023 and 2022.
|  | Number of Shares (in Thousands) |  |  | Weighted-average Grant Date Fair Value (per Share) |
Non-vested, December 31, 2021 |  |  | 755 |  |  | $ | 26.72 |
Granted |  |  | 316 |  |  |  | 28.77 |
Vested |  |  | (213 | ) |  |  | 43.83 |
Forfeited |  |  | — |  |  |  | — |
Non-vested, December 31, 2022 |  |  | 858 |  |  | $ | 22.48 |
Granted |  |  | 103 |  |  |  | 40.64 |
Vested |  |  | (410 | ) |  |  | 17.14 |
Forfeited |  |  | (158 | ) |  |  | 30.63 |
Non-vested, December 31, 2023 |  |  | 393 |  |  | $ | 31.41 |
Granted |  |  | 73 |  |  |  | 32.77 |
Vested |  |  | (103 | ) |  |  | 26.68 |
Forfeited |  |  | (272 | ) |  |  | 32.84 |
Non-vested, December 31, 2024 |  |  | 91 |  |  | $ | 33.57 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration